Biotechnology and Bioprocess Engineering

, Volume 24, Issue 3, pp 464–475 | Cite as

Synthesis and Biological Evaluation of New Benzylidenethiazolidine-2,4-dione Derivatives as 15-hydroxyprostaglandin Dehydrogenase Inhibitors to Control the Intracellular Levels of Prostaglandin E2 for Wound Healing

  • Insun Yu
  • Dubok ChoiEmail author
  • Hee-Kyung Lee
  • Hoon ChoEmail author
Research Paper


A novel series of benzylidenethiazolidine-2,4-dione derivatives was synthesized and investigated for 15-hydroxyprostaglandin dehydrogenase (15-PGDH)-scavenging activity, PGE2 release, and wound-healing activity. Among the tested derivatives, seven compounds (3, 9, 11, 12, 13, 14, and 25) resulted in a 50% inhibition of 15-PGDH at concentrations between 0.07 and 0.2 µM and increased PGE2 levels from 300 to over 600% in A549 cells treated with 5.0 and 10.0 µM of the compounds for 12 h. A scratch wound-healing assay using HaCaT cell line was conducted to verify the effects of 10 µM of these compounds on cell regeneration. The closure rate of the scratch wound healing showed that all compounds (3, 9, 11, 12, 13, 14, and 25) had greater wound regeneration effects than the cell growth factor, TGF-β1, which was used as the positive control. In particular, (Z)-N-benzyl-4-((2,4-dioxothiazolidin-5-ylidene)methyl)benzamide (compound 14) showed that the highest wound closure rate, which was 360%; this is about 3.6-fold higher than that of TGF-β1. Overall, these results show that compound 14 may be considered a promising candidate for the development of novel wound-healing agents.


benzylidenethiazolidine-2,4-dione 15-PGDH-scavenging activity PGE2 release wound-healing agent 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.



This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1D1A1B04930255).


  1. 1.
    Sanon, S., D. A. Hart, and E. E. Tredget (2016) Molecular and cellular biology of wound healing and skin regeneration, Medicine, New York, Elsevier Inc., pp. 162–184.Google Scholar
  2. 2.
    Jeong, B. S. (2006) Structure-activity relationship study of asiatic acid derivatives for new wound healing agent. Arch. Pharma. Res. 29: 556–562.CrossRefGoogle Scholar
  3. 3.
    Halehatty, P., N. Prakash, S. Halehatty, N. Bhojya, R. Thangali, N. Ravikumar, N. Raja, K. Gouthamchandra, R. Mahmood, and B. M. Khadeer Ahame (2009) Synthesis of novel benzo[h]quinolines. European J. Med. Chem. 44: 981–989.CrossRefGoogle Scholar
  4. 4.
    Patrulea, V., N. Hirt-Bur, A. Jeannerat, L. A. Applegate, V. Ostafe, and O. G Jordan (2016) Borchard, Peptide-decorated chitosan derivatives enhance fibroblast adhesion and proliferation in wound healing. Carbohydrate Poly. 142: 114–123.CrossRefGoogle Scholar
  5. 5.
    Patrulea, V., V. Ostafe, G. Borchard, and O. Jordan (2015) Chitosan as a starting material for wound healing applications. European J. Pharma. Biopharma. 97: 417–426.CrossRefGoogle Scholar
  6. 6.
    Davidson, J. M., L. B. Nanney, K. N. Broadley, J. S. Whitsett, A. M. Aquino, M. Beccaro, and A. Rastrelli (1991) Hyaluronate derivatives and their application to wound healing. Clinical Mater. 8: 171–177.CrossRefGoogle Scholar
  7. 7.
    Valacchi, G., G Grisci, C. Sticozzi, Y. S. Lim, M. Paolino, G. Giuliani, R. Mendichi, G Belmonte, R. Artusi, A. Zanardi, P. Garofalo, G. Giorgi, A. Cappelli, and L. Rovati (2015) Wound healing properties of hyaluronan derivatives bearing ferulate residues. J. Mater. Chem. 35: 7037–7045.CrossRefGoogle Scholar
  8. 8.
    Lee, J. S., K. R. Lee, S. R. Lee, H.J. Lee, H. S. Yang, J. H. Yeo, J. M. Park, B. H. Choi and E. K. Hong (2017) Polysaccharides isolated from liquid culture broth of Inonotus obliquus inhibit the invasion of human non-small cell Lung carcinoma cells. Biotechnol. Bioprocess Eng. 22: 45–51.CrossRefGoogle Scholar
  9. 9.
    Oh, M. S., Y. J. Kim, Y. J. Son, H. S. Yoo, and J. H Park (2017) Promotive effects of human induced pluripotent stem cell- conditioned medium on the proliferation and migration of dermal fibroblasts. Biotechnol. Bioprocess Eng. 22: 561–568.CrossRefGoogle Scholar
  10. 10.
    Manjal, S. K., R. Kaur, R. Bhatia, K. Kumar, V. Singh, R. Shankar, R. Kaur, and R. K. Rawal (2017) Synthetic and medicinal perspective of thiazolidinones. Bioorganic Chem. 75: 406–423.CrossRefGoogle Scholar
  11. 11.
    Jo, D. R., Y. O. Kim, R. Kim, Y. C. Chang, D. B. Choi, and H. Cho (2017) Novel rhodanine derivatives are selective algicides against Microcystis aeruginosa. Biotechnol. Bioprocess Eng. 22: 748–757.Google Scholar
  12. 12.
    You, D. S., Y. W. Lee, D. B. Choi, Y. C. Chang, and H. Cho (2017) Algicidal effects of thiazolinedione derivatives against Microcystis aeruginosa, Korean J. Chem. Eng. 34: 139–149.CrossRefGoogle Scholar
  13. 13.
    Choi, D. B., S. J. Yu, S. H. Baek, Y. H. Kang, Y. C. Chang, and H. Cho (2016) Synthesis and algicidal activity of new dichloro- benzylamine derivatives against harmful red tides. Biotechnol. Bioprocess Eng. 21: 463–476.CrossRefGoogle Scholar
  14. 14.
    Cho, H. and H. H. Tai (2002) Thiazolidinediones as a novel class of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors. Arch. Biochem. Biophys. 405: 247–251.CrossRefGoogle Scholar
  15. 15.
    Wu, Y., H. H. Tai, and H. Cho (2010) Synthesis and SAR of thiazolidinedione derivatives as 15-PGDH inhibitors. Bioorg. Medicin. Chem. 18: 1428–1433.CrossRefGoogle Scholar
  16. 16.
    Niesen, F. H., L. Schultz, A. Jadhav, C. Bhatia 1, K. Guo, D. J. Maloney, E. S. Pilka, M. Wang, U. Oppermann, T. D. Heightman, and A. Simeonov (2010) High-affinity inhibitors of human NAD -dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure activity relationships. PLoS One 5: 13719–13722.CrossRefGoogle Scholar
  17. 17.
    Wu, Y., S. D. Karna, C. H. Choi, M. Tong, H. H. Tai, D. H. Na, C. H. Jang, and H. Cho (2011) Synthesis and biological evaluation of novel thiazolidinedione analogues as 15-Hydroxyprostaglandin dehydrogenase inhibitors. J. Med. Chem. 54: 5260–5264.CrossRefGoogle Scholar
  18. 18.
    Choi, D. B., Y. L. Piao, Y. Wub, and H. Cho (2013) Control of the intracellular levels of prostaglandin E2 through inhibition of the 15-hydroxyprostaglandin dehydrogenase for wound healing. Bioorganic Med. Chem. 21: 4477–4484.CrossRefGoogle Scholar
  19. 19.
    Piao, Y.L., S. A. Ram, and H. Cho (2015) Cell-based biological evaluations of 5-(3-bromo-4-phenethoxybenzylidene)thiazolidine- 2,4-dione as promising wound healing agent. Bioorganic Med. Chem. 23: 2098–103.CrossRefGoogle Scholar
  20. 20.
    Clark, R. A (1996) The molecular and cellular biology of wound repair, 2nd ed.; New York, Plenum, pp. 188–206.Google Scholar
  21. 21.
    Martin, P. (1997) Wound healing—aiming for perfect skin regeneration. Science 276: 75–81.CrossRefGoogle Scholar
  22. 22.
    Werner, S. and R. Grose (2003) Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83: 835–870.CrossRefGoogle Scholar
  23. 23.
    Kolodsick, J. E., M. Peters-Golden, J. Larios, G. B. Toews, V. J. Thannickal, and B. B. Moore (2003) Prostaglandin E inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. American J. Resp. Cell Mole. Bio. 29: 537–544.CrossRefGoogle Scholar

Copyright information

© The Korean Society for Biotechnology and Bioengineering and Springer 2019

Authors and Affiliations

  1. 1.Department of Polymer Science & EngineeringChosun UniversityGwangjuKorea
  2. 2.Biotechnology LaboratoryB-K Company LtdJeonbukKorea
  3. 3.Beauty & Cosmetic Management, Business SchoolCHA UniversitySeongnamKorea

Personalised recommendations